Copyright © 2002 by the European Society of Cardiology.
Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A.
revised December 11, 2001; accepted December 12, 2001
Abstract
Aims To determine the influence of diabetes on outcome after percutaneous coronary intervention in patients with prior coronary artery bypass grafting.
Methods and Results Patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention from 1 January 1996, to 31 August 2000, were divided into two groups based on whether or not they had diabetes, excluding patients with acute infarction or shock. Cox proportional hazards models were utilized to estimate the association between diabetes and adverse events. One thousand one hundred and fifty-three post-coronary artery bypass grafting percutaneous coronary intervention patients were identified (326 diabetics and 827 non-diabetics). Diabetics were younger, more likely to have hypertension, heart failure, and lower ejection fraction. Procedural characteristics and angiographic and procedural success rates were similar. Diabetes was associated with increased mortality (hazard ratio 1·58, 95% confidence intervals 1·102·27). Diabetes did not have a significant effect on mortality in patients treated for single-territory coronary disease (hazard ratio 1·44, 95% confidence intervals 0·693·02), but did in patients with multi-territory disease (hazard ratio 1·79, 95% confidence intervals 1·162·76). However, in diabetics with multi-territory disease who were completely revascularized with percutaneous coronary intervention, mortality was comparable to non-diabetics (hazard ratio 1·32, 95% confidence intervals 0·573·03).
Conclusion Among percutaneous coronary intervention patients with prior coronary artery bypass grafting, diabetes portends an adverse prognosis.Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved .
Key Words: Coronary artery bypass grafting, diabetes, percutaneous coronary intervention, mortality
f1 Correspondence: Verghese Mathew, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, U.S.A.
References
- J Am Coll Cardiol. 2000;35:11221129
[Abstract/Free Full Text] - Detre KM, Guo P, Holubkov R. Coronary revascularization in diabetic patients: A comparison of the randomization and observational components of the Bypass Angioplasty. Revascularization Investigation. Circulation. 1999;99:633640
[Abstract/Free Full Text] - Barsness GW, Peterson ED, Ohman EM. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 1997;96:25512556
[Abstract/Free Full Text] - Campeau L, Lesperance J, Hermann J, Carbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation. 1979;60:15[Abstract]
- Bourassa MG, Enjalbert M, Campeau L. Progression of coronary artery disease between 10 and 12 years after coronary artery bypass graft surgery. Roskamm H. Prognosis of Coronary Heart Disease. Berlin: Springer-Verlag; 1983. p. 150
- Frick MH, Valle M, Harjola PT. Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol. 1983;52:681685[CrossRef][ISI][Medline]
- Hwang MH, Meadows WR, Palac RT. Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. J Am Coll Cardiol. 1990;16:10661070[Abstract]
- Pick AW, Mullany CJ, Orszulak TA, Daly RC, Schaff HV. Third and fourth operations for myocardial ischemia: short-term results and long-term survival. Circulation. 1997;96:2631
- Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open-heart surgery in New York state. An analysis of risk factors and hospital mortality rates. JAMA. 1990;264:27682774[Abstract]
- Loop FD, Lytle BW, Cosgrove DM. Reoperation for coronary atherosclerosis. Changing practice in 2,509 consecutive patients. Annals Surg. 1990;212:378386[CrossRef][ISI][Medline]
- Lytle BW, Loop FD, Cosgrove DM. Fifteen hundred coronary reoperations: results and determinants of early and late survival. J Thoracic Cardiovasc Surg. 1987;93:847859[Abstract]
- Lytle BW, Loop FD, Taylor PC. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thoracic Cardiovasc Surg. 1993;105:605614[Abstract]
- Mathew V, Clavell AL, Lennon RJ, Grill DE, Holmes DR Jr. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: Changes in patient characteristics and outcome during two decades. Am J Med. 2000;108:127135[CrossRef][ISI][Medline]
- Van Belle E, Ketelers R, Bauters C. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up. Circulation. 2001;103:12181224
[Abstract/Free Full Text] - Van Belle E, Bauters C, Hubert E. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation. 1997;96:14541460
[Abstract/Free Full Text] - Rozenman Y, Sapoznikov D, Mosseri M. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. J Am Coll Cardiol. 1997;30:14201425[Abstract]
- Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR Jr. Comparison of percutaneous interventions for unstable angina pectoris in patients with and without prior coronary artery bypass grafting. Am J Cardiol. 2000;86:931937[CrossRef][ISI][Medline]
- Stephan WJ, O'Keefe JH, Piehler JM. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol. 1996;28:11401146[Abstract]
- Ernst SM, van der Feltz TA, Ascoop CA. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. Long-term results. J Thoracic Cardiovasc Surg. 1987;93:268275[Abstract]
- Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000;35:992998
This article has been cited by other articles:
![]() |
P.G. Steg and L.J. Feldman Percutaneous coronary intervention in diabetics with prior coronary artery bypass surgery: sweet or sour? Eur. Heart J., September 2, 2002; 23(18): 1411 - 1412. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
